Leadership

TransCode's senior leadership team combines decades of oncology drug discovery and development expertise,  to add both scientific insight and valuable strategic perspective to address cancer and create a sustainable commercialization product pipeline. 

Executive Team

R. ​Michael Dudley
Founder, President & CEO

Zdravka Medarova, PhD
Founder/Chief Technology Officer

Tom Fitzgerald, MBA
CFO, VP of Administration

Susan Duggan, RN, MBA
Sr. VP of Operations

Dustan Bonnin, CVA, MBA
VP of Strategy & Innovation

Peter Liu, PhD
         VP Drug Discovery            Chief Scientist

Alan Freidman
​VP Investor & Client Relations

Subrata Ghosh, PhD
​Principal Scientist

Ram Bhat, PhD
​Sr. Director CMC
In Memoriam 1961-2023

---

Board of Directors

Philippe Calais, PhD
​Board Chair

Magda Marquet, PhD
​Director

Erik Manting, PhD
​Director

Michael Dudley, President, CEO and Director

Tom Fitzgerald
CFO, Director

---

Advisory Board

Anna Moore, PhD
​Founder

Keith Flaherty, MD

Raghu Kalluri, MD, PhD

George Calin, MD, PhD

Dejan Juric, MD

---

Dmitry Samarsky
​PhD

G. Susan Srivatsa
​PhD

Raul Mostoslavsky
​MD, PhD

Lubomir Nechev
​PhD

Frank J.Slack
​PhD

---

Mehmet Yigit
​PhD

Betsabeh Madani Hermann
​MBA​, MENG

Jerome Lewis
​PhD, MBA

John Henneman III
​JD

Oliver Steinbach
​PhD